Product Information
ADZENYS XR-ODT 12.5 MG TABLET is a brand product labeled by Neos Therapeutics Brands, LLC, priced at $19.2127 per EA under NDC 70165002030. Its NADAC has been published 505 times since Dec 21, 2016.
FDA first approved this application on Jan 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
70165002030
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA204326FDA Approved
1/27/2016
TE Code
AB
On Market Since
2/16/2016
Pharmacological Classes
Price Statistics
The NADAC for ADZENYS XR-ODT 12.5 MG TABLET has been published 505 times since Dec 21, 2016, and over the history we have for it it has risen 119.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.2127 per EA |
|---|---|
| All-time high | $19.3521 (Jan 14, 2026) |
| All-time low | $8.7428 (Dec 21, 2016) |
| 52-week high | $19.3521 |
| 52-week low | $19.2127 |
| Median price | $13.8891 |
| Average price | $13.6389 |
| Largest weekly change | +14.9% (Aug 13, 2025) |
| Weeks tracked | 505 |
| Tracking since | Dec 21, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADZENYS XR-ODT 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ADZENYS XR-ODT 12.5 MG TABLET, manufactured by Neos Therapeutics Brands, LLC, is $19.2127 per EA (NDC 70165002030), effective Aug 19, 2026.
How has the price of ADZENYS XR-ODT 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ADZENYS XR-ODT 12.5 MG TABLET has risen 119.8%. It has been tracked across 505 weekly CMS publications since Dec 21, 2016.
What are the highest and lowest recorded NADAC prices for ADZENYS XR-ODT 12.5 MG TABLET?
Since Dec 21, 2016, the NADAC for ADZENYS XR-ODT 12.5 MG TABLET has ranged from a low of $8.7428 (Dec 21, 2016) to a high of $19.3521 (Jan 14, 2026), with a median of $13.8891 per EA.
Are there cheaper alternatives to ADZENYS XR-ODT 12.5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMPHETAMINE ER 12.5 MG ODT, is $16.2480 per EA — about 15% below ADZENYS XR-ODT 12.5 MG TABLET.
Who manufactures ADZENYS XR-ODT 12.5 MG TABLET?
ADZENYS XR-ODT 12.5 MG TABLET (NDC 70165002030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a brand product.